Duality Biologics
DualityBio is a clinical stage company focusing on the discovery and development of the next generation ADC therapeutics to treat patients in cancer and autoimmune diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD491—736m (Dealroom.co estimates May 2021.)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
$90.0m | Series B | ||
Total Funding | CAD123m |